메뉴 건너뛰기




Volumn 36, Issue 9, 2007, Pages 741-744

Children and autism: Part 1 - recognition and pharmacological management

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

EID: 36048982090     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (11)

References (31)
  • 1
    • 0037265148 scopus 로고    scopus 로고
    • Parent mediated early intervention for young children with autism spectrum disorder
    • Diggle T, McConachie HR, Randle VR. Parent mediated early intervention for young children with autism spectrum disorder. Cochrane Database Syst Rev 2003(1): CD003496.
    • (2003) Cochrane Database Syst Rev , Issue.1
    • Diggle, T.1    McConachie, H.R.2    Randle, V.R.3
  • 2
    • 0035347694 scopus 로고    scopus 로고
    • Technical report: the pediatrician's role in the diagnosis and management of autistic spectrum disorder in children
    • Committee on Children With Disabilities.
    • Committee on Children With Disabilities. Technical report: the pediatrician's role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics 2001a;107:e85.
    • (2001) Pediatrics , vol.107
  • 3
    • 84870469320 scopus 로고    scopus 로고
    • Diagnostic and statistical manual of mental disorders
    • 4th edn text revised ed. Washington DC: APA,American Psychiatric Association.
    • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edn text revised ed. Washington DC: APA, 2000.
    • (2000)
  • 5
    • 31144444162 scopus 로고    scopus 로고
    • Epidemiology of autistic disorder and other pervasive developmental disorders
    • Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry 2005;66:3-8.
    • (2005) J Clin Psychiatry , vol.66 , pp. 3-8
    • Fombonne, E.1
  • 6
    • 0141427915 scopus 로고    scopus 로고
    • Epidemiological surveys of autism and other pervasive developmental disorders: an update
    • Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Devel Disord 2003b;33:365-82.
    • (2003) J Autism Devel Disord , vol.33 , pp. 365-382
    • Fombonne, E.1
  • 7
    • 0037218815 scopus 로고    scopus 로고
    • The prevalence of autism
    • Fombonne E. The prevalence of autism. JAMA 2003b;289:87-9.
    • (2003) JAMA , vol.289 , pp. 87-89
    • Fombonne, E.1
  • 10
    • 0036691815 scopus 로고    scopus 로고
    • Autism, an extreme challenge to integrative medicine. Part 1: the knowledge base
    • Kidd PM. Autism, an extreme challenge to integrative medicine. Part 1: the knowledge base. Altern Med Rev 2002a;7:292-316.
    • (2002) Altern Med Rev , vol.7 , pp. 292-316
    • Kidd, P.M.1
  • 11
  • 14
    • 0037663836 scopus 로고    scopus 로고
    • Early behavioural abnormalities in children with autistic disorder
    • Young R, Brewer N, Pattison C. Early behavioural abnormalities in children with autistic disorder. Autism 2003;7:125-43.
    • (2003) Autism , vol.7 , pp. 125-143
    • Young, R.1    Brewer, N.2    Pattison, C.3
  • 15
    • 0023508704 scopus 로고
    • Behavioral treatment and normal educational and intellectual functioning in young autistic children
    • Lovaas OI. Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol 1987;55:3-9.
    • (1987) J Consult Clin Psychol , vol.55 , pp. 3-9
    • Lovaas, O.I.1
  • 16
    • 0027478910 scopus 로고
    • Long term outcomes for children with autism who received early intensive behavioral treatment
    • McEachin JJ, Smith T, Lovaas OI. Long term outcomes for children with autism who received early intensive behavioral treatment. Am J Ment Retard 1993;97:359-72.
    • (1993) Am J Ment Retard , vol.97 , pp. 359-372
    • McEachin, J.J.1    Smith, T.2    Lovaas, O.I.3
  • 18
    • 84880284221 scopus 로고    scopus 로고
    • Guidelines for levels and kinds of evidence to support indications and claims: for non-registrable medicines including complementary medicines and other listed medicines
    • Available at,[Accessed 1 April 2006].Therapeutic Goods Administration.
    • Therapeutic Goods Administration. Guidelines for levels and kinds of evidence to support indications and claims: for non-registrable medicines including complementary medicines and other listed medicines. Available at www. tga.gov.au/docs/pdf/tgaccevi.pdf [Accessed 1 April 2006].
  • 19
    • 33748062026 scopus 로고    scopus 로고
    • Oxford handbook of psychiatry
    • New York: Oxford University Press
    • Semple D. Oxford handbook of psychiatry. New York: Oxford University Press, 2005.
    • (2005)
    • Semple, D.1
  • 20
    • 27744466024 scopus 로고    scopus 로고
    • Randomised, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity
    • Research Units on Pediatric Psychopharmacology Autism Network.
    • Research Units on Pediatric Psychopharmacology Autism Network. Randomised, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 2005;62:1266-74.
    • (2005) Arch Gen Psychiatry , vol.62 , pp. 1266-1274
  • 21
    • 13944264748 scopus 로고    scopus 로고
    • A placebo controlled cross over trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism
    • Hollander EAP, Chaplin W, Zagarsky K, et al. A placebo controlled cross over trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 2005;30:582-9.
    • (2005) Neuropsychopharmacology , vol.30 , pp. 582-589
    • Hollander, E.A.P.1    Chaplin, W.2    Zagarsky, K.3
  • 22
    • 0033746434 scopus 로고    scopus 로고
    • Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotinin reuptake inhibitors
    • McDougle CJ, Kresch LE, Posey DJ. Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotinin reuptake inhibitors. J Autism Devel Disord 2000;30:427-35.
    • (2000) J Autism Devel Disord , vol.30 , pp. 427-435
    • McDougle, C.J.1    Kresch, L.E.2    Posey, D.J.3
  • 24
    • 84880259061 scopus 로고    scopus 로고
    • Adverse Drug Reactions Advisory Committee (ADRAC)
    • Dated 15th October 2004. Replaces statement of 17th June
    • Adverse Drug Reactions Advisory Committee (ADRAC). Use of SSRI antidepressants in children and adolescents. Dated 15th October 2004. Replaces statement of 17th June 2004.
    • (2004) Use of SSRI antidepressants in children and adolescents
  • 25
    • 25144437833 scopus 로고    scopus 로고
    • Use of antipsychotics in children and adolescents
    • Findling RL, Steiner H, Weller EB. Use of antipsychotics in children and adolescents. J Clin Psychiatry 2005;66(Supp 7):29-40.
    • (2005) J Clin Psychiatry , vol.66 , Issue.SUPP 7 , pp. 29-40
    • Findling, R.L.1    Steiner, H.2    Weller, E.B.3
  • 26
    • 0021219334 scopus 로고
    • Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms
    • Anderson LT, Campbell M, Grega M, Perry R, Small AM, Green WH. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry 1984;141:1195-202.
    • (1984) Am J Psychiatry , vol.141 , pp. 1195-1202
    • Anderson, L.T.1    Campbell, M.2    Grega, M.3    Perry, R.4    Small, A.M.5    Green, W.H.6
  • 27
    • 0024402021 scopus 로고
    • The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children
    • Anderson LT, Campbell M, Adams P, Small AM, Perry R, Shell J. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. J Autism Devel Disord 1989;19:227-39.
    • (1989) J Autism Devel Disord , vol.19 , pp. 227-239
    • Anderson, L.T.1    Campbell, M.2    Adams, P.3    Small, A.M.4    Perry, R.5    Shell, J.6
  • 28
    • 16644370679 scopus 로고    scopus 로고
    • Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders
    • Shea S, Turgay A, Carroll A, et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 2004;114:e634-e41.
    • (2004) Pediatrics , vol.114
    • Shea, S.1    Turgay, A.2    Carroll, A.3
  • 29
    • 21344434103 scopus 로고    scopus 로고
    • Risperidone treatment of autistic disorder: long term benefits and blinded discontinuation after 6 months
    • Paediatric Psychopharmacology Autism Network.
    • Paediatric Psychopharmacology Autism Network. Risperidone treatment of autistic disorder: long term benefits and blinded discontinuation after 6 months. Am J Psychiatry 2005;162:1361-9.
    • (2005) Am J Psychiatry , vol.162 , pp. 1361-1369
  • 30
    • 8144220313 scopus 로고    scopus 로고
    • Aripiprazole for maladaptive behavior in pervasive developmental disorders
    • Stigler KA, Posey DJ, McDougle CJ. Aripiprazole for maladaptive behavior in pervasive developmental disorders. J Child Adolesc Pharmacol 2004;14:455-63.
    • (2004) J Child Adolesc Pharmacol , vol.14 , pp. 455-463
    • Stigler, K.A.1    Posey, D.J.2    McDougle, C.J.3
  • 31
    • 2442546569 scopus 로고    scopus 로고
    • Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses
    • McConville BJ, Sorter MT. Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses. J Clin Psychiatry 2004;65:20-9.
    • (2004) J Clin Psychiatry , vol.65 , pp. 20-29
    • McConville, B.J.1    Sorter, M.T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.